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Utilization of Hydrophilic Swellable Polymers as Carriers for Sustained 
Drug Delivery from Matrices and Three Layer Tablet Systems 
Marilena Vlachou, Hani Naseef and Manuel Efentakis* 
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Athens, Panepistimiopolis, Zografou, 
157 71 Athens, Greece 
Abstract: The purpose of this research was to develop and evaluate different sustained release preparations, using swella-
ble polymers as carriers in the form of matrices and three-layer tablets. These preparations may offer a number of thera-
peutic advantages over immediate release dosage forms in drug delivery. The materials used for the fabrication of these 
systems were hydrophilic swellable polymers namely Metolose, Polyox, Xanthan gum and an erodible material Gantrez, 
acting as drug(diclofenac sodium) carriers. he powder characteristics determined for these polymers suggest good flow-
ability with the exception of Gantrez. The addition of 1% of magnesium stearate resulted in improved flow properties for 
all polymers including Gantrez. Tablets were prepared by direct compression whereas three-layer tablets were prepared by 
compressing polymer barrier layers on both sides of the core containing the drug. Our findings show that both prepara-
tions exhibit sustained release characteristics; also the structure of the device considerably affects the drug release and the 
release rate. Furthermore erosion and swelling greatly influence the overall behavior, function and performance of the sys-
tems. Finally kinetic analysis studies indicated that the drug release mechanisms were also affected by these effects.  
Keywords: Sustained release, swelling, erosion, matrix, three layer tablets. 
INTRODUCTION 
 The preparation of suitable drug delivery systems is de-
pendent on the selection of the appropriate carrier/ingredient 
capable of controlling delivery. Most sustained release pre-
parations are based on polymeric materials. These materials, 
in particular hydrophilic swellable polymers are promising 
versatile carriers for the manufacturing of sustained release 
systems. These systems may offer a number of therapeutic 
advantages in drug delivery over conventional (immediate 
release) dosage forms of some drugs since they allow the 
release of various therapeutic agents to be controlled, and 
thus play a significant role in the development of novel oral 
dosage forms. The characteristic feature of these systems is 
that the rate of drug absorption may be adjusted through a 
controlled rate of drug release from the dosage forms. Their 
advantages include extended pharmacological cover, reduced 
dosing frequency, a decreased incidence of adverse effects 
and a reduction in drug plasma fluctuation resulting in a 
more constant therapeutic effect [1]. 
 Different types of oral controlled release formulations 
such as matrix tablets [2], capsules [3,4] and mini matrices 
[5] have been developed to improve treatment and clinical 
efficiency. Recently multi-layer tablets are gaining impor-
tance in the design of oral sustained drug delivery systems 
[6,7]. These systems consist of an active matrix core and one 
or more barriers applied during tabletting. The barriers delay 
the interaction of the core with the dissolution medium by 
reducing the surface available for drug release by limiting 
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liquid penetration. These formulations are designed to deli-
ver the drugs at controlled and predetermined rate, thus 
maintaining their therapeutically effective concentrations in 
systemic circulation for prolonged periods of time. Depend-
ing on the material properties these formulations may swell, 
gel, erode and finally dissolve in the gastrointestinal tract. 
The control of the release is mainly determined by the com-
position of each layer. The multi-layer systems permit the 
production of various tablet structures of different release 
properties achieving thus a range of dissolution profiles. La-
yered tablets show a number of advantages and greater flexi-
bility in obtaining different drug release profiles such as zero 
order, bimodal, pulsatile and controlled release [6].The most 
frequently used ingredients-carriers of these systems as men-
tioned above are the polymers. A variety of polymers is em-
ployed since their nature and characteristics may play a key 
role and significantly influence the behavior of these devices
 
[8]. The controlling effect of a polymer material on drug 
release depends on its physicochemical properties and the 
way it is mixed during the manufacture of the system. Spe-
cifically this effect is due to the polymers’ molecular proper-
ties, such as the nature of the monomer, type and degree of 
substitution and whether the polymer is mixed dry or disso-
lved. In general three main types of polymers may be used: 
natural, synthetic and semi-synthetic [9]. These materials 
may swell or not, can be porous, non-porous, semipermea-
ble, impermeable, erodible, non-erodible, etc. 
 In the present study matrix tablets and multi-layer tablet 
system were developed and evaluated. The aim of this study 
was to prepare matrices and three layer tablet system and 
then investigate the effect of a) the structure of the system b) 
the influence of the features of the particular polymeric ma-
terials on the drug release rate and c) to evaluate the behavior 
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of the systems prepared in this investigation. Three hydro-
philic swellable polymers hydroxyl propylmethyl cellulose, 
polyethylene oxide, xanthan gum and a rather erodible and 
moderately swellable material poly(methyl vinyl ether/ mal-
eic anhydride), of different nature and properties were em-
ployed as ingredients-carriers. In order to investigate and 
evaluate their behavior, a rather water soluble drug diclof-
enac sodium was used as model drug. 
EXPERIMENTAL 
Materials 
 The following chemicals were obtained from commercial 
suppliers and used as received: Diclofenac sodium (D) (Sig-
ma Chemical Co, USA), hydroxypropylmethyl cellulose 
[Metolose 90,100.000 SR] (M),(Shin-Etsu, Tokyo, Japan), 
polyethylene oxide [Polyox NF,MW 7x10
6
] (P) (Union Car-
bide, Danbury, CT, USA), Xanthan gum (XG) (Aldrich, US-
A), poly(methyl vinyl ether/maleic anhydride) [Gantrez AN-
169 BF] (G) (CAF, N.J. USA) and magnesium stearate (BD-
H, Dorset,UK). Also, a well known commercial sustained 
release product (VOLTAREN marketed by Novartis) in the 
form of sustained release coated tablet was examined too. 
All chemicals used in this study were of analytical quality. 
Powder Characteristics  
 The techniques used for the determining the powder 
characteristics were described in earlier studies [4]. 
Tablet Preparation  
 The matrix tablets were consisted of 49.5 w/w % of dic-
lofenac sodium, 49.5% of polymers and 1% of magnesium 
stearate, and are listed in Table 1. The drug and the polymers 
were mixed in a Turbula (Type T2C) mixer (Willy A. Bac-
hofen AG, Basel, Switzerland) for 10 min. Tablets of 200 mg 
mass were compressed using 10 mm diameter flat faced pun-
ches in a Carver laboratory hydraulic press (Fred S. Carver, 
Inc., Menomonce Falls, W) to a crushing strength 10 kg, me-
asured in the Erweka hardness tester(Erweka, Heusenstamm, 
Germany). 
 Three-layer tablets were similarly prepared by direct 
compression procedure using, 10 mm diameter flat faced pu-
nches. The die was accurately and progressively filled with 
weighed amounts of different mixtures, i.e. barrier layer, co-
re layer and barrier layer once again. First, the barrier layer 
was placed in the bottom of the die and compressed at ap-
proximately 100 kg, the core layer was then added and com-
pressed at 100 kg followed finally by the top layer barrier 
which was added and compressed at 500 kg. The core layer 
was consisted of Polyox or Metolose and diclofenac sodium 
whereas the barrier layers consisted of pure polymer. The 
three-layer tablet formulations prepared are listed in Table 2. 
The number 3 indicates three-layer tablet formulations. For 
tablet composition and notations see Tables 1 and 2 below. 
In Vitro Drug Release Studies 
 Tablets were subjected to the dissolution study at 37± 0.5 
0
C under stirring at 100 rpm (paddle method) in the USP 
XXIII dissolution apparatus II (Pharmatest, Hainburg, Ger-
many), in 900 ml of phosphate buffer(pH 7.4). Samples(5 
ml) were withdrawn at predetermined time intervals, filtered 
and analyzed at 276 nm for sodium diclofenac using a 
Perkin–Elmer UV spectrophotometer (Norwalk, CT, USA ). 
An equivalent volume of temperature-equilibrated fluid was 
replaced in the dissolution bath following removal of every 
sample. The data represent the mean values of at least three 
separate experiments. Results are given as mean ± standard 
deviation. 
 Dissolution efficiency (DE) data were obtained using the 
following equation. The concept of DE was introduced first 
by Khan and Rhodes who suggested that it is a parameter 
useful for the evaluation of in vitro dissolution.  
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 where y is the percentage of dissolved product, and DE 
the area under the dissolution curve between time points t1 
and t2 expressed as a percentage of the curve at maximum 
dissolution, y100 over the same time period [10]. When a rela-
tionship is to be shown between dissolution and another 
variable, it is considered more realistic to use DE, which 
takes into account the dissolution profile as a whole [10]. In 
addition, where a quantitative comparison is required, DE is 
Table 1.  Formulation Compositions of Matrix Tablets (in mg). 
Tablets Ingredients 
 
Diclofenac 
Sodium 
Metolose 
Xanthan 
Gum 
Gantrez Polyox Mg.St t240 DE±S.D. n 
PGD 99   49.5 49.5 2 15 16.5±0.5 1.05 
MGD 99 49.5  49.5  2 75 63.5±2.1 1.20 
PXD 99  49.5  49.5 2 44 40.5±0.9 0.80 
MXD 99 49.5 49.5   2 38 37.0±2.0 0.81 
Voltaren       50 47.0±1.6  
Mg.St = Magnesium stearate t240 = % drug released at 240 min 
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Table 2.  Formulation Compositions of Three Layer Tablets (in mg). 
Tablets Diclofenac Sodium Metolose Xanthan Gum Polyox Gantrez Mg.St DE±S.D. n 
TL   24.75   0.25 
ML 99 49.5    1.5 3MDX 
BL   24.75   0.25 
19.0±0.8 1.00 
TL     24.75 0.25 
ML 99 49.5    1.5 3MDG 
BL     24.75 0.25 
25.0±1.4 B.R. 
TL  24.75    0.25 
ML 99 49.5    1.5 3MDM 
BL  24.75    0.25 
22.5±1.2 0.96 
TL   24.75   0.25 
ML 99   49.5  1.5 3PDX 
BL   24.75   0.25 
23.0±1.1 0.89 
TL     24.75 0.25 
ML 99   49.5  1.5 3PDG 
BL     24.75 0.25 
26.0±1.7 B.R. 
TL    24.75  0.25 
ML 99   49.5  1.5 3PDP 
BL    24.75  0.25 
21.5±0.9 0.90 
TL = top layer,  ML = medium layer,  BL = bottom layer  B.R. = Bimodal release 
Mg.St = Magnesium stearate . 
a more suitable parameter and when limits are set on DE it 
can be used in quality control in place of the conventional 
dissolution level. 
Uptake and Erosion Studies 
 Weighed tablets were placed in flat bottom dissolution 
vessels, containing the dissolution medium under the condi-
tions of temperature and stirring described in the dissolution 
studies section above. To prevent floating, tablets were pla-
ced under a bell shape “tent” formed by a pre-weighted 4 cm 
x 4 cm metal mesh (no 10) square. At selected time intervals 
an individual tablet was withdrawn using the mesh “ tent “. 
The mesh and the tablet were blotted to remove excess water 
and then weighed on a Sartorius analytical balance. Then the 
wetted tablets were dried in an oven at 60 
o
C for a 48 hours 
period after that, before weighing. They were cooled in a 
desiccator and finally weighed. This process was repeated 
until a constant weight was achieved (final dry weight). 
Three different tablets were measured at each time point, and 
fresh tablets were used for each individual time point. The 
extent of erosion (E) was determined by, 
E% = 100 (Wi - Wf) / Wi           (2) 
 Where, Wi and Wf are the initial starting dry weight and 
final dry weight of the same dried and partially eroded tablet, 
respectively. Also, the increase in weight(water uptake) due 
to absorbed liquid (A) was calculated at each time point by 
A% = 100 (Ww – Wf) / Wf                        (3) 
 Where, Ww is the mass of the wet tablet before drying. 
Optical Examination  
 Morphological tablet changes were examined with a 
video camera (JVC TK-C11381, Japan) fitted with a zoom 
lens (Century Precision Optics AD-5870, USA) and conne-
cted to a monitor. The light system was consisted of a fluo-
rescent tube fitted under the beaker. The beaker was covered 
to exclude external light. The tablet was held on a pin and 
placed in a dissolution beaker with 900 ml of dissolution 
medium at 37 ± 0.5 
0
C under stirring at 100 rpm, to allow 
observation of changes in the device. The beaker was re-
moved, at predetermined time intervals, from the dissolution 
apparatus and photographed by means of the video camera. 
Statistical Analysis 
 Results given as mean ± standard deviation (S.D.), were 
analyzed using student’s t-test (P < 0.05). 
RESULTS AND DISCUSSION 
 Polymeric materials used in controlled delivery formula-
tions include hydrophobic, insoluble and erodible or hydro-
philic polymers. In this study, the materials used were men-
tioned earlier in the introduction. As model drug was used a 
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rather soluble drug, diclofenac sodium, with solubility of 
18.8 mg/ml [11]. 
 he powder characteristics determined for the polymers 
are summarized in Table 3. The Hausner ratio and compres-
sibility (%) were used to evaluate the flow properties of pol-
ymers. These parameters are commonly used to assess pow-
der flowability and are useful indices, which reflect the flow 
and packing behavior of powders. The Hausner ratio values 
display very good flow properties for all polymers with the 
exception of Gantrez. The percentage compressibility was 
computed from the density data shown in Table 3. The com-
pressibility values coincide with the Hausner ratio values, 
suggesting good flowability for these materials. The addition 
of 1% of magnesium stearate resulted in improved flow 
properties for all polymers including Gantrez (Table 3). 
Thus, these materials are suitable used for the preparation of 
tablet drug delivery systems. 
 The structure of the three layers devices are shown in 
Fig. (1). It is clear that in these formulations the core (or 
middle layer) has both surfaces (top and bottom) covered. 
Upon contact with the dissolution medium, swellable poly-
mer matrices form a viscous gelatinous mass. As the hydra-
tion progresses the entrapped drug dissolves and diffuses 
through the swollen network, which after a while undergoes 
erosion. In three layer tablets the external layers cover the 
core tablet and usually act as barriers, since typically they 
consist of pure polymer [6,7,12]. With time they hydrate, 
swell and as a result they hinder drug dissolution and release. 
At the end of the process they tend to erode and the surface 
available for drug release slowly increases. 
 As seen in Table 1, the matrices are composed of polym-
er mixtures and diclofenac sodium. Three layer tablets con-
tained drug only in the middle layer (core) while top and 
bottom layers, Fig. (1) were drug free acting as barriers (Ta-
ble 2). 
 In the next sections we provide an evaluation of their 
performance, release behavior and a mechanistic approach of 
how these are affected by tablet’s structure and composition. 
Swelling and Erosion Studies 
 It is clear from, Tables 1 and 2, that the formulations ex-
amined consist of different polymers or polymer mixtures. 
As mentioned earlier these materials have different charac-
teristics, which could influence their performance. Two im-
portant characteristics of the polymers employed, i.e. their 
liquid uptake (swelling) and loss of weight (erosion) were 
evaluated in order to examine whether these properties are 
interrelated and to what extent, with each formulations’ be-
havior and how they affect the system’s function and per-
formance. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Schematic diagram of the three layer tablet system. 
 
 The results obtained are illustrated in Figs. (2 and 3). The 
changes in weight represent water uptake and maximum 
swelling. Visual observations showed that the tablets ap-
peared swollen almost from the beginning of the experiment. 
The only exception was the Gantrez tablets in which gel de-
velopment appeared rather negligible. The swelling of the 
matrices increased gradually with time and the maximum 
being measured at 8 h. MGD, however, showed a gradual 
increase up to 4 h (maximum swelling) and then started to 
decrease drastically Fig. (2). It is clear that PGD showed the 
fastest and greatest swelling (1600%), followed by PXD 
(1400%), MXD(1300%) and last MGD(650 %). 
 The swelling results of three layer tablets are illustrated 
in Fig. (3). The uptake of these tablets appeared comparable 
and increased gradually until the end of the experiment, dis-
playing maximum swelling in the region of 1500%, with the 
exception of Gantrez tablets which exhibited their maximum 
approximately at 6 h and after that time a rapid decrease was 
noticed. 
Table 3.  Powder Characteristics. 
Polymer Bulk Density is dB ± SD Tap Density is dT ± SD 
Compressibility % (Carr 
Index) dT -dB/dT ± SD 
Hausner Ratio dT/dB ± SD 
 Mg.St=0          Mg.St=1% Mg.St=0        g.St=1% Mg.St=0      Mg.St=1% Mg.St=0      Mg.St=1% 
Metolose  0.40± 0.012     0.42±0.011 0.47±0.010    0.48±0.012 14.00±0.12  12.00±0.13 1.17±0.007   1.14±0.009 
Polyox  0.34± 0.009     0.38±0.009 0.39±0.008    0.42±0.011 12.00±0.11  10.00±0.11 1.14±0.006   1.11±0.007 
Xanthan gum 0.61±0.015     0.64±0.017 0.73±0.014    0.75±0.016 16.40±0.10   14.50±0.13 1.20±0.005    1.17±0.008 
Gantrez  0.22±0.007     0.26±0.010 0.29±0.006    0.32±0.010 24.00±0.12   19.00±0.15 1.31±0.008    1.23±0.011 
Data shown are means n = 5 Mg.St = magnesium stearate 
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Fig. (2). Percentage of weight changes (water uptake) as function of 
time for matrices. Each point represents the mean value of the three 
samples and error bars show ± S.D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Percentage of weight changes (water uptake) as function of 
time for three layer tablets. Each point represents the mean value of 
the three samples and error bars show ± S.D 
 
 Erosion results, expressed here by loss of weight, are 
shown in Figs. (4 and 5). The highest degree of erosion was 
observed in MGD matrices (totally eroded in 6 h), followed 
by PXD, MXD and PGD, which displayed a slower and pro-
gressive weight loss with time Fig. (4). Their erosion ap-
peared to be lower than that of MGD since only between 35 
to 60% eroded, a process which was also visually noticed. 
 
 
 
 
 
 
 
 
 
Fig. (4). Percentage of weight loss (erosion) from matrices after 
exposure to the medium. Each point represents the mean value of 
the three samples and error bars show ± S.D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Percentage of weight loss (erosion) from three layer tablets 
after exposure to the medium. Each point represents the mean value 
of the three samples and error bars show ± S.D. 
 
 Similarly, in Fig. (5) three layer’s tablet erosion results 
are shown. The erosion of Metolose formulations Fig. (5a) 
are comparable to these of 3MDG and it is clear that the lat-
ter displayed the highest erosion(60%) followed by 3MDM 
and 3MDX with 45% and 40%, respectively. As far as the 
Polyox formulations are concerned, 3PDG displayed the hig-
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hest erosion(65%), followed by 3PDX with 56% and then 
3PDP with 40%, Fig. (5b). 
Device Structure and Drug Release 
 The release profile depends on the type and properties of 
the polymer used, but dissolution of the active compound is 
always a prior and necessary step of the release process. Liq-
uid penetration into the matrix is the first step followed by 
dissolution of the drug and finally its diffusion. The proce-
dure depends on successive dissolution and diffusion, once 
the dissolution medium penetrates the matrix. 
 In Figs. (6 and 7) the release profiles of diclofenac so-
dium are illustrated. In Fig. (6) the VOLTAREN profile is 
included for comparison although it is a different form of 
sustained release (membrane release), manufactured by a 
different methology. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Release profiles from diclofenac sodium matrices and 
VOLTAREN. Each point represents the mean value of the three 
samples and error bars show ± S.D.  
 
 As can be observed in Figs. (6 and 7) the drug release 
and release rates differ considerably between the matrices 
and three layer tablets. All three layer tablets exhibited a 
singificant ( P<0.01) lower release than the matrices with the 
exception of PGD. Moreover, all formulations demonstrated 
a sustained mode of release. 
 As it can be seen from the release profiles depicted in 
Fig. (6) the extent of drug release varies among the formula-
tions and is affected by the composition of the tablet and the 
properties of the contained materials as indicated by the t240 
and D.E. values (Table 1). Among the matrices, MGD 
showed the highest drug release (it was fully released in 6 h) 
followed by VOLTAREN, PXD, MXD and the PGD, which 
exhibited approximately 73%, 72%, 65% and 35% release in 
8 h, respectively. It is apparent that no remarkable differ-
ences exist between VOLTAREN and PXD, MXD. 
 Findings from earlier studies revealed that the release of 
diclofenac sodium from HPMC matrices [11] was in the 
range of 60%, at the same time, while its release from Xan-
than gum formulations varied, depending on the drug/polym-
er ratio and matrices dimensions [13,14]. Image analysis 
photos show that at 2 to 3 h period MGD matrices were suf-
fered from increased shrinking compared to PGD Fig. (8).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (7). Release profiles from diclofenac sodium three layer tab-
lets. Each point represents the mean value of the three samples and 
error bars show ± S.D.  
 
Moreover, polymer particles probably Gantrez detached 
from the surface of MGD matrices and gradually dissolved, 
Fig. (8) resulting in the erosion and deterioration of the ma-
trix. On the contrary, this phenomenon was not observed in 
PGD matrices, which maintained their integrity whilst their 
mass expanded, Fig. (8) and as a result lower drug release 
was noticed in this case. This different behavior could be 
attributed to the limited swelling-expansion of Metolose tab-
lets compared to the corresponding Polyox. Due to its greater 
swelling, Polyox, can hold in more efficiently the Gantrez 
particles and hence blockade their detachment and erosion 
/dissolution. Thus, drug release results clearly coincide with 
the swelling and erosion properties of the different types of 
polymers used. In parallel, Xanthan gum matrices, PXD and 
MXD, demonstrated an intermediate level of swelling, ero-
sion and consequently drug release. A comparison between 
these formulations with VOLTAREN is rather inappropriate 
due to the difference in the release procedure and mecha-
nism. 
 On the other hand, drug release particularly, from multi-
layer systems, appears more complicated since the move-
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Fig. (8). Morphological changes in radial plane of the matrices 
during dissolution after 2 and 3 hours. 
 
ment of drug molecules is also affected by the structure of 
the system and the existing barriers. It is known that in mul-
tilayer systems the matrix core usually contains the drug and 
the external layers incorporated during tabletting modulate 
(delay) the interaction of the drug with the dissolution me-
dium by limiting the surface available for the solute release 
and at the same time controlling liquid penetration. Thus 
they act as barriers since typically they consist of pure poly-
mer [7,12] and as a result they obstruct drug dissolution and 
release. This is achieved by intercepting water penetration, 
into the protected core for a period of time and this reduces 
hydration rate and controlled area for solute release at the 
core. During the dissolution process, the barriers may swell 
(hydrophilic polymers) and expand. With time these swollen 
barriers tend to erode and the surface available for drug re-
lease slowly increases. 
 With the exception of PGD Fig. (6) three layer tablets 
displayed lower release Fig. (7) compared to the matrices. In 
parallel, these tablets up to 90 min displayed a similar behav-
ior and then their release mode tends to differentiate. The 
presence of the different polymers (Polyox or Metolose), 
contained in the middle tablet layer (core), did not differenti-
ate their release rates, as seen from the DE values, of Table 
2. Tablets containing Polyox demonstrated a slightly higher 
release compared to corresponding Metolose tablets. In par-
allel, the presence of Gantrez and Xanthan gum in external 
layers did not alter the systems performance considerably, 
even though Gantrez formulations displayed a higher release. 
It is therefore reasonable to expect that a modification of 
external layer thickness or an increase in the quantity of pol-
ymer in these layers could considerably affect drug release 
from these multilayer delivery systems. 
 Visual observations point out, that the external layers 
absorb liquid and expand creating a swellable barrier. This 
results to a substantial increase in the diffusion pathway for 
the drug molecules and consequently the drug release is de-
creased. At the same time the middle layer starts to hydrate 
and a fraction of the drug was released from that layer, 
mainly from the lateral surface. As hydration progressed, the 
layers continued to swell and then merged and formed a 
solid polymer mass [7]. This development facilitates the hin-
drance of drug molecules movement and additionally de-
creases their diffusion out. 
 In general, drug release from the solid polymer mass is 
affected by the entanglement or disentanglement of polymer 
chains and particularly by the rate of detachment of the poly-
mer chains from the matrix surface [15], causing changes in 
the diffusional pathway and finally erosion of the system. 
Indeed Polyox formulations exhibited greater erosion than 
the respective Metolose Fig. (5). 
 In Fig. (9) typical images of diclofenac three layer tablets 
undergoing hydration-swelling and the changes in their mor-
phology after 60,120 and 360 min are illustrated. Analogous 
changes were observed with all the three layer tablets exam-
ined (not shown). In these photographs the recorded time 
intervals were chosen in order to reveal some of the major 
changes occurring during the dissolution process. 
 
 
 
 
Fig. (9). Morphological changes of the three layer tablets during dissolution 1, 2 and 6 hours. 
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 Moreover, Gantrez tablets 3MDG and 3PDG demon-
strated a biphasic release, Fig. (7). Both formulations exhibi-
ted a slow initial release phase (0-180min), followed by a 
fast release phase(240-480min). These coincide with their 
erosion, which is sharply increased after 180 min Figs. (5a, 
b) and as a consequence the release increased after 210-240 
min. Erosion shortens the travel distance of dissolved drug 
molecules from the dissolution front to the surrounding me-
dium and this matches the increase of drug release. 
 The bar graphs shown in Fig. (10) illustrate the release 
data from 3MDM, 3PDP and 3MDX preparations, presented 
as the rate of drug release (percent dissolved per hour) versus 
time. The graph clearly shows that these formulations dis-
played a fairly constant drug release rate, which corresponds 
to about 5-7% per hour. 
 
 
 
 
 
 
 
 
Fig. (10). Rate of drug release (% of drug release / hour) as a func-
tion of time. 
 
 The findings indicate that in the three layered tablet sys-
tem formulations and in particular 3MDG and 3PDG, the 
polymers act as carriers. These formulations represent a very 
promising dosage form for the administration of rather solu-
ble drugs, such as diclofenac sodium with a bimodal release. 
As previously mentioned above bimodal release involves 
two variable release phases: slow drug delivery at the begin-
ning of the dissolution procedure, followed by a faster re-
lease in a subsequent phase. This bimodal release could be 
particularly suitable for the treatment of symptoms exhibit-
ing circadian rhythms[16]. Naturally bioavailability studies 
would offer a more comprehensive picture of the pharmacol-
ogical and therapeutic capabilities of these formulations; 
however these could be the subject of another study. 
Kinetics and Mechanism of Drug Release 
 From the data presented above it becomes obvious that 
the properties of the polymers, the structure and the mor-
phology of the tablet considerably influence the drug release 
and release rate. Furthermore a biphasic release was demon-
strated by 3MDG and 3PDG, a development which was also 
reported in earlier studies [16,17]. Bimodal release seemed 
to occur in two phases. An initial gelation phase (where the 
gel mass expands due to water penetration) during which 
some initial erosion of the polymer was noticed and a frac-
tion of the drug is released, followed by a second phase, 
where, upon complete hydration of the polymer mass frag-
mentation of the gel occurred, which resulted in another in-
crease in the rate of drug release. Similar results were re-
ported by Shah et al and Munday [17-19]. This behaviour 
was attributed either to pH changes [18] or separation of the 
layers [20] or due to the different polymer properties [4]. 
 In our investigation biphasic release is apparently associ-
ated with the presence and the properties of Gantrez in the 
respective formulations. Visual observations revealed, as 
previously mentioned, that after hydration of the tablets and 
as the process advances, particles of the material were gradu-
ally removed from the Gantrez tablets. Subsequently, the 
detached particles slowly dissolved and this was continued 
until the material was entirely eroded. 
 Fig. (7) shows the biphasic release of these formulations. 
Clearly, the curves are comprised of an initial and terminal 
release phase. The “ break ” between the two phases becom-
es apparent at 180 min. 
 In Table 4 the release rate constants for each phase are 
listed. Judging by the correlation coefficients, following re-
gression analysis, both the initial and terminal release phases 
exhibit zero-order type release kinetics. 
 In order to elucidate the mechanism of drug release, the 
data were further analyzed using the familiar equation pro-
posed by Korsmeyer and Peppas [21]. 
Mt /M = k t 
n                                  (4) 
 Mt is the amount of the drug released at time t, M is the 
amount of drug released over a very long time, which corre-
sponds in principle to the initial loading, k is the kinetic con-
stant and n is the diffusional exponent which depends on the 
release mechanism. For a cylindrical matrix values n = 0.5 
indicate Fickian release, values 0.45<n<0.89 indicate anoma-
lous release kinetics (coupled diffusion /relaxation) and 
0.89<n<1 indicate a zero order release also known as purely 
relaxation-controlled drug release. 
 The values we obtained for the diffusional exponent, n, 
ranged from 0.80 to 1.21 demonstrating that the release mec-
hanism varies. The calculated n values are shown in Tables 1 
and 2. The VOLTAREN n value was not estimated since the 
above equation can be used only for swellable matrices. 
Gantrez matrices displayed n values > 1, indicating near zero 
order release mechanism, which may be attributed to swel-
ling and erosion/dissolution of the polymer a fact confirmed 
by the swelling and erosion studies [22]. On the other hand 
Xantham gum formulations displayed n values < 0.89 sug-
gesting a coupling of diffusional and relaxation mechanisms, 
called anomalous diffusion. Three layer tablets displayed n 
values 0.89<n<1 indicating a zero order release. 
CONCLUSIONS  
 It is evident that all preparations exhibited sustained re-
lease delivery. Moreover, it was demonstrated that the com-
position of the mixture may influence and modulate the drug 
release and the rate of release from the matrices used. It is 
also apparent that the properties of materials (particularly 
erosion) contained in the matrix affect considerably the re-
lease mode. Similarly, modulation of drug release also achie-
ved in the three layer tablets and was influenced by the poly-
mer properties and the drug release behavior of the system. 
The polymeric barriers modified (depending on the mate-
rial’s properties) the dissolution of the drug molecules by 
controlling the penetration of the surrounded dissolution 
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medium altering thus the diffusion path. It is therefore up to 
the formulator to select which dosage forms cover better the 
required specifications. Gantrez formulations displayed fast-
er release due to its less swelling and greater erosion. 
Moreover, Metolose formulations displayed an increased 
release compared to the corresponding Polyox formulations. 
Overall, it appears that tablet structure and the properties of 
the materials containing in the dosage forms used considera-
bly influence drug release, release rates and mechanism of 
release. In addition, due to their bimodal release mode, 
3MDG and 3PDG, seem appropriate for the treatment of 
symptoms exhibiting circadian rhythms. 
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Table 4. Kinetic Parameters of Diclofenac Sodium Tablets Using Zero-Order Model. 
 Total Release  0 - 480 Min Initial Release 0 - 180 Min Terminal Release 240 - 480 Min  
Tablets k(min
-1
) ±  S.D. r k1(min-1) ±  S.D. r k2(min-1) ±  S.D. r k2/ k1 
3MDG 0.1011 0.0005 0.957 0.0334 0.0047 0.989 0.1442 0.0004 0.995  4.31 
3PDG 0.1282 0.0006 0.946 0.0452 0.0009 0.982 0.1913 0.0003 0.996  4.23 
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